Published by Ikaba Koyi on 27th July 2017
(ShareCast News) - Liquid biopsy company Angle reported a rise in revenues but widening losses in its unaudited on Thursday, as well as publishing positive results from studies which it said indicated its 'Parsortix' system could potentially detect ovarian cancer.
URL: http://www.digitallook.com/dl/news/story/26243294/...